DS
PGEN icon

Dudley & Shanley’s Precigen PGEN Stock Holding History

Dudley & Shanley’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-16,898
Closed -$406K – 30
2014
Q2 		$406K Buy
16,898
+5,833
+53% +$118K 0.08% 26
2014
Q1 		$278K Buy
+11,065
New +$306K 0.06% 27

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
GTP
Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Dudley & Shanley's PGEN Position: Q3 2014 in Review

Dudley & Shanley sold out of Precigen (PGEN) in Q3 2014, closing a stake of 16,898 shares — an estimated $406K sold.

Dudley & Shanley first reported a position in PGEN in Q1 2014 and held it in 2 quarters. The position peaked at $406K in Q2 2014. 102 funds tracked by Wall St. Rank hold PGEN as of Q3 2014.

  • Dudley & Shanley reported no remaining Precigen position as of Q3 2014 after selling out during the quarter.
  • Dudley & Shanley sold 16,898 Precigen shares in Q3 2014, an estimated $406K.
  • Dudley & Shanley first reported a position in Precigen in Q1 2014 and held it in 2 quarters.
  • Dudley & Shanley's Precigen position peaked at $406K in Q2 2014.
  • 102 funds tracked by Wall St. Rank held Precigen as of Q3 2014.

Based on Dudley & Shanley's 13F filing for Q3 2014, filed 17 Oct 2014.